Simultaneous determination of icotinib, osimertinib, aumolertinib, and anlotinib in human plasma for therapeutic drug monitoring by UPLC-MS/ MSJOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSISIF3.12024-12-011OAAI
Mechanisms and Molecular Targets of BuShenHuoXue Formula for OsteoarthritisACS OMEGAIF4.32022-01-275OAAI
Efficacy and safety of HER2 inhibitors in combination with or without pertuzumab for HER2-positive breast cancer: a systematic review and meta-analysisBMC CANCERIF3.42019-10-2134OAAI
Quantification of 1D, a novel derivative of curcumin with potential antitumor activity, in rat plasma by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study in ratsPHARMACEUTICAL BIOLOGYIF4.82019-04-244OAAI
Ceritinib Alone for Crizotinib-naive Versus Crizotinib-pretreated for Management of Anaplastic Lymphoma Kinase-rearrangement Non-Small-cell Lung Cancer: ASystematic ReviewCLINICAL LUNG CANCERIF3.32018-11-011PREAI
DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against Aβ-induced neuronal damage via the Akt/JNK signaling pathwayACTA PHARMACOLOGICA SINICAIF8.42016-08-0832OAAI
Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10INTERNATIONAL IMMUNOPHARMACOLOGYIF4.72015-07-0139PREAI
Pharmacokinetic study of salvianolic acid D after oral and intravenous administration in ratsACTA PHARMACEUTICA SINICA BIF14.62015-05-0114OAAI
The role of leptin in obesity and the potential for leptin replacement therapyENDOCRINEIF2.92012-12-2938PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项